Exelixis Inc (NAS:EXEL)
$ 36.04 0.19 (0.53%) Market Cap: 10.29 Bil Enterprise Value: 9.22 Bil PE Ratio: 23.10 PB Ratio: 4.53 GF Score: 91/100

Exelixis Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript

May 11, 2021 / 06:00PM GMT
Release Date Price: $24.69 (-1.04%)
Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research

Good day, everybody. Thanks for joining us at the Virtual Bank of America Annual Health Care Conference. I am Jason Gerberry, SMID cap biotech analyst, and I'm pleased to be introducing our next company presenter, Exelixis and CEO, Mike Morrissey. So Mike, thanks so much for joining us once again.

Michael M. Morrissey
Exelixis, Inc. - CEO, President & Director

It's great to be here, Jason. Thanks again for the invite. Just before we begin, I'll remind everybody that I'm making forward-looking statements today. So please see our SEC filings for a description of the risks that we face in our business.

Questions & Answers

Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research

Great. So I guess, first off, what a difference a year makes. About a year ago, we were talking about the kinetics of renal cancer market and how that was leading to a decline in CABOMETYX. And now CABOMETYX is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot